HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Persistence of autonomous ovarian activity after discontinuation of therapy for precocious puberty in McCune-Albright syndrome.

AbstractOBJECTIVE:
The aim of this study was to evaluate the possibility of persistence of autonomous ovarian activity in girls with McCune-Albright syndrome (MAS) after withdrawal of medroxyprogesterone therapy administered for precocious puberty.
DESIGN, SETTING, AND PARTICIPANTS:
Five girls with MAS were followed-up 1.2 to 8.5 years after the end of treatment. The girls underwent luteinizing hormone-releasing hormone (LH-RH) tests, estradiol (E2) basal measurement, and pelvic ultrasound two times in the follow-up period.
RESULTS:
Menses resumed in four of five girls, 1.4 +/- 0.9 years after the end of treatment, at chronologic age of 11.3 +/- 1.3 years. Cycles for all girls were irregular. Three patients presented inadequate E2 levels (from 56 to 320 pg/mL) associated with low or absent gonadotropin response to LH-RH tests. The pelvic ultrasound showed ovarian cysts at the time of the study.
CONCLUSION:
These hormonal and ultrasonographic findings provide evidence of persistence of autonomous ovarian activity in some young women with MAS.
AuthorsM E Escobar, M Gryngarten, H Domené, G Ropelato, M R López, C Bergadá
JournalJournal of pediatric and adolescent gynecology (J Pediatr Adolesc Gynecol) Vol. 10 Issue 3 Pg. 147-51 (Aug 1997) ISSN: 1083-3188 [Print] United States
PMID9288659 (Publication Type: Journal Article)
Chemical References
  • Progesterone Congeners
  • Estradiol
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Medroxyprogesterone
Topics
  • Child
  • Estradiol (blood)
  • Female
  • Fibrous Dysplasia, Polyostotic (blood, complications, physiopathology)
  • Follicle Stimulating Hormone (blood)
  • Follow-Up Studies
  • Humans
  • Luteinizing Hormone (blood)
  • Medroxyprogesterone (therapeutic use)
  • Ovary (diagnostic imaging, physiopathology)
  • Progesterone Congeners (therapeutic use)
  • Puberty, Precocious (blood, complications, drug therapy, physiopathology)
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: